Has Parkinson’s treatment really changed?

Back in June the Parkinson’s Academy hosted “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma. Now in its second year the meeting was a sell-out again and expectations were high. Chaired by Dr Peter Fletcher (Gloucestershire Hospitals NHS Foundation Trust), the meeting was designed to cater to the diverse needs […]

Continue Reading »

Drug recall for Parkinson’s and epilepsy

3 July, 2019 | Posted in:

This week, three drugs used to treat aspects of Parkinson’s and epilepsy were recalled following concerns that the medicines had been improperly stored prior to reaching patients. The drugs in question, Neupro, Vimpat and Clexane with a B & S Healthcare label, have been recalled by the Medicines and Healthcare products Regulatory Agency (MHRA) as […]

Continue Reading »

Early research suggests groundbreaking changes afoot for Parkinson’s

1 May, 2019 | Posted in: ,

Parkinson’s is a neurological condition that affects many elements of day to day functionality, changing a person’s experience of their everyday life. One of these elements is movement, with freezing, stumbling and falling all common symptoms of Parkinson’s. A recent pilot study in Canada has seen some radical changes in patient’s walking, resulting from electrical […]

Continue Reading »

Getting prepped – where will your project take you?

25 April, 2019 | Posted in:

The Neurology Academy’s unique blend of education puts a heavy emphasis on the practical, and integral to our Parkinson’s Advanced MasterClasses is the inter-module project. For some this can be an exciting opportunity to get stuck into an audit, or service development project that they have been waiting impatiently to carry out, but for others it […]

Continue Reading »

What’s next in Research Engagement? You tell us!

8 March, 2019 | Posted in:

6th December 2018 saw the Parkinson’s Academy team up with The Cure Parkinson’s Trust for our first ever dedicated research engagement. The highly-rated event covering a range of topics from the getting a project off the ground to the challenges faced, from engaging people with Parkinson’s to ensuring a project is deliverable. Established and reputable […]

Continue Reading »

Last chance to enter the UK Parkinson’s Excellence Network Awards

22 February, 2019 | Posted in:

There is still time to enter your service team for the 2019 UK Parkinson’s Excellence Network Conference and Awards. Showcase the great care your team is delivering and help make it standard for people affected by Parkinson’s across the UK. All Parkinson’s Advanced MasterClass delegates are invited to submit improvement projects as an award entry […]

Continue Reading »

Is disease modification in Parkinson’s a reality?

13 February, 2019 | Posted in:

CPT’s Dr Richard Wyse opened the meeting by discussing whether disease modification in Parkinson’s could be a reality. As we know, Parkinson’s symptomatic therapies have many imperfections. Encouragingly there is research into both better symptomatic and disease modifying treatments. At CPT however our sole focus is to is to halt progression of the disease and ultimately to reverse it. The charity has preclinical and regenerative medicine programmes, but it also [...]

Continue Reading »

Finding research; how you can find out about Parkinson’s research opportunities

30 January, 2019 | Posted in:

The final session was presented by Parkinson’s UK’s Amelia Hursey who shared the charity’s new online trial resource called Taking Part which lists studies made searchable by postcode. The site was designed following detailed research with PwP (people with Parkinson's) who revealed that 70% of PwPs want to take part in research but only 24% have taken part. Many PwPs reported that they wanted to hear about [...]

Continue Reading »

Recruiting to research: Not all research is for everyone but there is something for everyone

23 January, 2019 | Posted in:

With the group, Jemma explored the obstacles to recruitment, highlighting that practical barriers such as visits to the clinic, travel, logistics, balancing clinical appointments with the demands of life, were all barriers. Additional concerns were medication (the fact that potential participants might be asked to take even more medication) and the way to [...]

Continue Reading »